EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Anti-CD44 Variant 9 Monoclonal Antibody C44Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers

Mayuki Tawara, Hiroyuki Suzuki iD, Nohara Goto, Tomohiro Tanaka, Mika K Kaneko iD, Yukinari Kato iD

Current Issues in Molecular Biology · 20.04.2023 · 45 (4) · 3658-3673

DOI: 10.3390/cimb45040238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 20.04.2023. Verfasst von Mayuki Tawara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cluster of differentiation 44 (CD44) is a type I transmembrane glycoprotein and has been shown to be a cell surface marker of cancer stem-like cells in various cancers. In particular, the splicing variants of CD44 (CD44v) are overexpressed in cancers and play critical roles in cancer stemness, invasiveness, and resistance to chemotherapy and radiotherapy. Therefore, the understanding of the function of each CD44v is indispensable for CD44-targeting therapy. CD44v9 contains the variant 9-encoded region, and its expression predicts poor prognosis in patients with various cancers. CD44v9 plays critical roles in the malignant progression of tumors. Therefore, CD44v9 is a promising target for cancer diagnosis and therapy. Here, we developed sensitive and specific monoclonal antibodies (mAbs) against CD44 by immunizing mice with CD44v3–10-overexpressed Chinese hamster ovary-K1 (CHO/CD44v3–10) cells. We first determined their critical epitopes using enzyme-linked immunosorbent assay and characterized their applications as flow cytometry, western blotting, and immunohistochemistry. One of the established clones, C44Mab-1 (IgG1, kappa), reacted with a peptide of the variant 9-encoded region, indicating that C44Mab-1 recognizes CD44v9. C44Mab-1 could recognize CHO/CD44v3–10 cells or colorectal cancer cell lines (COLO201 and COLO205) in flow cytometric analysis. The apparent dissociation constant (KD) of C44Mab-1 for CHO/CD44v3–10, COLO201, and COLO205 was 2.5 × 10−8 M, 3.3 × 10−8 M, and 6.5 × 10−8 M, respectively. Furthermore, C44Mab-1 was able to detect the CD44v3–10 in western blotting and the endogenous CD44v9 in immunohistochemistry using colorectal cancer tissues. These results indicated that C44Mab-1 is useful for detecting CD44v9 not only in flow cytometry or western blotting but also in immunohistochemistry against colorectal cancers.

Schlagwörter

Stichwörter der Autor:innen

CD44CD44v9colorectal cancermonoclonal antibody

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
  • Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.

ORCID-Profile: Hiroyuki Suzuki, Mika K Kaneko, Yukinari Kato

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Tawara, M., Suzuki, H., Goto, N., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). A Novel Anti-CD44 Variant 9 Monoclonal Antibody C44Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers. Current Issues in Molecular Biology, 45(4), 3658-3673. https://doi.org/10.3390/cimb45040238

Vancouver

Tawara M, Suzuki H, Goto N, Tanaka T, Kaneko MK, Kato Y. A Novel Anti-CD44 Variant 9 Monoclonal Antibody C44Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers. Current Issues in Molecular Biology. 2023;45(4):3658-3673. doi:10.3390/cimb45040238

BibTeX
@article{Tawara2023,
  author = {Tawara, Mayuki and Suzuki, Hiroyuki and Goto, Nohara and Tanaka, Tomohiro and Kaneko, Mika K and Kato, Yukinari},
  title = {A Novel Anti-CD44 Variant 9 Monoclonal Antibody C44Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers},
  journal = {Current Issues in Molecular Biology},
  year = {2023},
  volume = {45},
  number = {4},
  pages = {3658--3673},
  doi = {10.3390/cimb45040238}
}
Kostenlos starten →